Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis.
Bekaddour N, Smith N, Beitz B, Llibre A, Dott T, Baudry A, Korganow AS, Nisole S, Mouy R, Breton S, Bader-Meunier B, Duffy D, Terrier B, Schneider B, Quartier P, Rodero MP, Herbeuval JP.
Bekaddour N, et al. Among authors: schneider b.
Front Immunol. 2023 Sep 26;14:1178172. doi: 10.3389/fimmu.2023.1178172. eCollection 2023.
Front Immunol. 2023.
PMID: 37822935
Free PMC article.